Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart

Penn Startups Raising Capital – Spring 2022

Two Penn spinouts on the Technical.ly Philly RealLIST standout tech companies

ExynAI has been shortlisted as a finalist for a SXSW Innovation Award

Cogwear and Rezon to make brain enhancing wearable for athletes



Skip to content